CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Exercise or conversion Director acquired 15,282 shares (option exercise)
- 4 Grant or award Chief Commercial Officer acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 187,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Director gave up 43,590 shares (to pay taxes)
- 4 Grant or award Director acquired 6,623 shares (grant or award)
- 4 Grant or award Director acquired 6,623 shares (grant or award)
- 4 Grant or award Director acquired 6,623 shares (grant or award)
- 4 Grant or award Director acquired 6,623 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 8,947 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 40,198 shares (grant or award)
- 4 Grant or award Director acquired 6,865 shares (grant or award)
- 4 Grant or award Director acquired 6,865 shares (grant or award)
- 4 Grant or award Director acquired 6,865 shares (grant or award)
Page 12 of 15 · 296 filings